MedPointe Bringing Optivar Promotion In-House Starting In January

The company will end its co-promotion agreement with Bausch & Lomb for azelastine ophthalmic solution at year-end. MedPointe added 17 new allergy specialty reps in the quarter to detail the conjunctivitis agent.

More from Archive

More from Pink Sheet